Journal Mobile Options
Table of Contents
Vol. 29, No. 6, 2011
Issue release date: December 2011
Section title: Retracted Paper
Free Access
Dig Dis 2011;29:531–539
(DOI:10.1159/000332969)

Gut Microbiota and Pediatric Disease

Iebba V.b · Aloi M.a · Civitelli F.a · Cucchiara S.a
aPediatric Gastroenterology and Liver Unit, Department of Pediatrics, and bMicrobiology Unit, Department of Public Health Sciences, Sapienza University of Rome, Rome, Italy
email Corresponding Author


  

Key Words

  • Gut microbiota
  • Inflammatory bowel disease
  • Metagenomic studies
  • Pediatric diseases
  • Celiac disease
  • Asthma
  • Allergy
  • Autism


References

  1. Ghose C, Perez-Perez GI, Dominguez-Bello MG, Pride DT, Bravi CM, Blaser MJ: East Asian genotypes of Helicobacter pylori strains in Amerindians provide evidence for its ancient human carriage. Proc Natl Acad Sci USA 2002;99:15107–15111.
  2. O’Hara AM, Shanahan F: The gut flora as a forgotten organ. EMBO Rep 2006;7:688–693.
  3. Frank DN, Pace NR: Gastrointestinal microbiology enters the metagenomics era. Curr Opin Gastroenterol 2008;24:4–10.
  4. Peterson DA, Frank DN, Pace RN, Gordon JI: Metagenomic approaches for defining the pathogenesis of inflammatory bowel diseases. Cell Host Microbe 2008;3:417–427.
  5. Hattori M, Taylor TD: The human intestinal microbiome: a new frontier of human biology. DNA Res 2009;16:1–12.
  6. Neish AS: Microbes in gastrointestinal health and disease. Gastroenterology 2009;136:65–80.
  7. Ley RE, Peterson DA, Gordon JI: Ecological and evolutionary forces shaping microbial diversity in the human intestine. Cell 2006;124:837–848.
  8. Leser TD, Mølbak L: Better living through microbial action: the benefits of the mammalian gastrointestinal microbiota on the host. Environ Microbiol 2009;11:2194–2206.
  9. Eckburg PB, Bik EM, Bernstein CN, Purdom E, Dethlefsen L, Sargent M, Gill SR, Nelson KE, Relman DA: Diversity of the human intestinal microbial flora. Science 2005;308:1635–1638.
  10. Schloss PD, Handelsman J: Status of the microbial census. Microbiol Mol Biol Rev 2004;68:686–691.
  11. De Filippo C, Cavalieri D, Di Paola M, Ramazzotti M, Poullet JB, Massart S, Collini S, Pieraccini G, Lionetti P: Impact of diet in shaping gut microbiota revealed by a comparative study in children from Europe and rural Africa. Proc Natl Acad Sci USA 2010;107:14691–14696.
  12. Palmer C, Bik EM, Digiulio DB, Relman DA, Brown PO: Development of the human infant intestinal microbiota. PLoS Biol 2007;5:e177.
  13. Vanhoutte T, Huys G, Brandt E, Swings J: Temporal stability analysis of the microbiota in human feces by denaturing gradient gel electrophoresis using universal and group-specific 16S rRNA gene primers. FEMS Microbiol Ecol 2004;48:437–446.
  14. Leser TD, Mølbak L: Better living through microbial action: the benefits of the mammalian gastrointestinal microbiota on the host. Environ Microbiol 2009;11:2194–2206.
  15. Zoetendal EG, Akkermans AD, De Vos WM: Temperature gradient gel electrophoresis analysis of 16S rRNA from human fecal samples reveals stable and host-specific communities of active bacteria. Appl Environ Microbiol 1998;64:3854–3859.
  16. Vaughan EE, Schut F, Heilig HG, Zoetendal EG, de Vos WM, Akkermans AD: A molecular view of the intestinal ecosystem. Curr Issues Intest Microbiol 2000;1:1–12.
  17. Ley RE, Bäckhed F, Turnbaugh P, Lozupone CA, Knight RD, Gordon JI: Obesity alters gut microbial ecology. Proc Natl Acad Sci USA 2005;102:11070–11075.
  18. Mueller S, Saunier K, Hanisch C, Norin E, Alm L, Midtvedt T, Cresci A, Silvi S, Orpianesi C, Verdenelli MC, Clavel T, Koebnick C, Zunft HJ, Doré J, Blaut M: Differences in fecal microbiota in different European study populations in relation to age, gender, and country: a cross-sectional study. Appl Environ Microbiol 2006;72:1027–1033.
  19. Khachatryan ZA, Ktsoyan ZA, Manukyan GP, Kelly D, Ghazaryan KA, Aminov RI: Predominant role of host genetics in controlling the composition of gut microbiota. PLoS One 2008;3:e3064.
  20. Li M, Wang B, Zhang M, Rantalainen M, Wang S, Zhou H, Zhang Y, Shen J, Pang X, Zhang M, Wei H, Chen Y, Lu H, Zuo J, Su M, Qiu Y, Jia W, Xiao C, Smith LM, Yang S, Holmes E, Tang H, Zhao G, Nicholson JK, Li L, Zhao L: Symbiotic gut microbes modulate human metabolic phenotypes. Proc Natl Acad Sci USA 2008;105:2117–2122.
  21. Mahowald MA, Rey FE, Seedorf H, Turnbaugh PJ, Fulton RS, Wollam A, Shah N, Wang C, Magrini V, Wilson RK, Cantarel BL, Coutinho PM, Henrissat B, Crock LW, Russell A, Verberkmoes NC, Hettich RL, Gordon JI: Characterizing a model human gut microbiota composed of members of its two dominant bacterial phyla. Proc Natl Acad Sci USA 2009;106:5859–5864.
  22. Gill SR, Pop M, Deboy RT, Eckburg PB, Turnbaugh PJ, Samuel BS, Gordon JI, Relman DA, Fraser-Liggett CM, Nelson KE: Metagenomic analysis of the human distal gut microbiome. Science 2006;312:1355–1359.
  23. Turnbaugh PJ, Gordon JI: The core gut microbiome, energy balance and obesity. J Physiol 2009;587:4153–4158.
  24. Tschöp MH, Hugenholtz P, Karp CL: Getting to the core of the gut microbiome. Nat Biotechnol 2009;27:344–346.
  25. Arumugam M, Raes J, Pelletier E, et al: Enterotypes of the human gut microbiome. Nature 2011;473:174–180.
  26. Swidsinski A, Loening-Baucke V, Lochs H, Hale LP: Spatial organization of bacterial flora in normal and inflamed intestine: a fluorescence in situ hybridization study in mice. World J Gastroenterol 2005;11:1131–1140.
  27. Neish AS: Microbes in gastrointestinal health and disease. Gastroenterology 2009;136:65–80.
  28. Palmer C, Bik EM, DiGiulio DB, Relman DA, Brown PO: Development of the human infant intestinal microbiota. PLoS Biol 2007;5:e177.
  29. Penders J, Stobberingh EE, van den Brandt PA, Thijs C: The role of the intestinal microbiota in the development of atopic disorders. Allergy 2007;62:1223–1236.
  30. Khachatryan ZA, Ktsoyan ZA, Manukyan GP, et al: Predominant role of host genetics in controlling the composition of gut microbiota. PLoS One 2008;3:e3064.
  31. Mackie R, Sghrr A, Gaskins HR: Developmental microbial ecology of the neonatal gastrointestinal tract. Am J Clin Nutr 1999;69:1035–1045.
  32. Heavey PM, Rowland IR: The gut microflora of the developing infant: microbiology and metabolism. Microb Ecol Health Dis 1999;11:75–83.

    External Resources

  33. Schwiertz A, Gruhl B, Lobnitz M, Michel P, Radke M, Blaut M: Development of the intestinal bacterial composition in hospitalized preterm infants in comparison with breast-fed, full-term infants. Pediatr Res 2003;54:393–399.
  34. Favier CF, Vaughan EE, De Vos WM, Akkermans AD: Molecular monitoring of succession of bacterial communities in human neonates. Appl Environ Microbiol 2002;68:219–226.
  35. Coppa GV, Bruni S, Morelli L, Soldi S, Gabrielli O: The first prebiotics in humans: human milk oligosaccharides. J Clin Gastroenterol 2004;38:S80–S83.
  36. Harmsen HJ, Wildeboer-Veloo AC, Raangs GC, Wagendorp AA, Klijn N, Bindels JG, Welling GW: Analysis of intestinal flora development in breast-fed and formula-fed infants by using molecular identification and detection methods. J Pediatr Gastroenterol Nutr 2000;30:61–67.
  37. Fanaro S, Chierici R, Guerrini P, Vigi V: Intestinal microflora in early infancy: composition and development. Acta Paediatr Suppl 2003;91:48–55.
  38. Zoetendal EG, Akkermans ADL, De Vos WM: Temperature gradient gel electrophoresis analysis of 16S rRNA from human fecal samples reveals stable and host-specific communities of active bacteria. Appl Environ Microbiol 1998;64:3854–3859.
  39. Eckburg PB, Bik EM, Bernstein CN, et al: Diversity of the human intestinal microbial flora. Science 2005;308:1635–1638.
  40. Tannock GW, Cook G: Enterococci as members of the intestinal microflora of humans; in Gilmore MS (ed): The Enterococci: Pathogenesis, Molecular Biology, and Antibiotic Resistance. Washington, ASM Press, 2002, pp 101–132.
  41. Suau A, Bonnet R, Sutren M, et al: Direct analysis of genes encoding 16S rRNA from complex communities reveals many novel molecular species within the human gut. Appl Environ Microbiol 1999;65:4799–4807.
  42. Zoetendal EG, Ben-Amor K, Harmsen HJM, Schut F, Akkermans ADL, De Vos WM: Quantification of uncultured Ruminococcusobeum-like bacteria in human fecal samples by fluorescent in situ hybridization and flow cytometry using 16S rRNA-targeted probes. Appl Environ Microbiol 2002;68:4225–4232.
  43. Franks AH, Harmsen HJM, Raangs GC, Jansen GJ. Schut F, Welling GW: Variations of bacterial populations in human feces measured by fluorescent in situ hybridization with group-specific 16S rRNA-targeted oligonucleotide probes. Appl Environ Microbiol 1998;64:3336–3345.
  44. Satokari RM, Vaughan EE, Akkermans AD, Saarela M, de Vos WM: Bifidobacterial diversity in human feces detected by genus-specific PCR and denaturing gradient gel electrophoresis. Appl Environ Microbiol 2001;67:504–513.
  45. Heilig HG, Zoetendal EG, Vaughan EE, Marteau P, Akkermans ADL, De Vos WM: Molecular diversity of Lactobacillus spp. and other lactic acid bacteria in the human intestine as determined by specific amplification of 16S ribosomal DNA. Appl Environ Microbiol 2002;68:114–123.
  46. Liu CH, Lee SM, Vanlare JM, Kasper DL, Mazmanian SK: Regulation of surface architecture by symbiotic bacteria mediates host colonization. Proc Natl Acad Sci USA 2008;105:3951–3956.
  47. Turnbaugh PJ, et al: An obesity-associated gut microbiome with increased capacity for energy harvest. Nature 2006;444:1027–1031.
  48. Dethlefsen L, Relman DA: Incomplete recovery and individualized responses of the human distal gut microbiota to repeated antibiotic perturbation. Proc Natl Acad Sci USA 2011;108(suppl 1):4554–4561.
  49. Bach JF: The effect of infections on susceptibility to autoimmune and allergic diseases. N Engl J Med 2002;347:911–920.
  50. Worldwide variation in prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and atopic eczema: ISAAC. The International Study of Asthma and Allergies in Childhood (ISAAC) Steering Committee. Lancet 1998;351:1225–1232.
  51. Masoli M, Fabian D, Holt S, Beasley R: The global burden of asthma: executive summary of the GINA Dissemination Committee report. Allergy 2004;59:469–478.
  52. Gore C, et al: Bifidobacterium pseudocatenulatum is associated with atopic eczema: a nested case-control study investigating the fecal microbiota of infants. J Allergy Clin Immunol 2008;121:135–140.
  53. Young SL, et al: Bifidobacterial species differentially affect expression of cell surface markers and cytokines of dendritic cells harvested from cord blood. Clin Diagn Lab Immunol 2004;11:686–690.
  54. Ouwehand AC, et al: Differences in Bifidobacterium flora composition in allergic and healthy infants. J Allergy Clin Immunol 2001;108:144–145.
  55. Sepp E, et al: Intestinal microflora of Estonian and Swedish infants. Acta Paediatr 1997;86:956–961.
  56. Noverr MC, Huffnagle GB: Does the microbiota regulate immune responses outside the gut? Trends Microbiol 2004;12:562–568.
  57. Sartor R: Microbial influences in inflammatory bowel diseases. Gastroenterology 2008;134:577–594.
  58. Garrett WS, Lord GM, Punit S, et al: Communicable ulcerative colitis induced by T-bet deficiency in the innate immune system. Cell 2007;131:33–45.
  59. Strober W, et al: The fundamental basis of inflammatory bowel disease. J Clin Invest 2007;117:514–521.
  60. Peyrin-Biroulet L, et al: Antimycobacterial therapy in Crohn’s disease: game over? Gastroenterology 2007;132:2594–2598.
  61. Darfeuille-Michaud A, et al: High prevalence of adherent-invasive Escherichia coli associated with ileal mucosa in Crohn’s disease. Gastroenterology 2004;127:412–421.
  62. Tannock GW: The search for disease-associated compositional shifts in bowel bacterial communities of humans. Trends Microbiol 2008;16:488–495.
  63. Guigoza Y, Dore JI, Schiffrina EJ: The inflammatory status of old age can be nurtured from the intestinal environment. Curr Opin Clin Nutr Metab Care 2008;11:13–20.
  64. Cartun RW, Van Kruiningen HJ, Pedersen CA, et al: An immunocytochemical search for infectious agents in Crohn’s disease. Mod Pathol 1993;6:212–219.
  65. Van de Merwe JP, Schroder AM, Wensinck F, Hazenberg MP: The obligate anaerobic faecal flora of patients with Crohn’s disease and their first-degree relatives. Scand J Gastroenterol 1988;23:1125–1131.
  66. Keighley MR, Arabi Y, Dimock F, Burdon DW, Allan RN, Alexander-Williams J: Influence of inflammatory bowel disease on intestinal microflora. Gut 1978;19:1099–1104.
  67. Hartley MG, Hudson MJ, Swarbrick ET, et al: The rectal mucosa-associated microflora in patients with ulcerative colitis. J Med Microbiol 1992;36:96–103.
  68. Peach S, Lock MR, Katz D, Todd IP, Tabaqchali S: Mucosal-associated bacterial flora of the intestine in patients with Crohn’s disease and in a control group. Gut 1978;19:1034–1042.
  69. Nieuwenhuis EES, Escher JC: Early onset IBD: what’s the difference? Dig Liver Dis 2008;40:12–15.
  70. Conte MP, Schippa S, et al: Gut-associated bacterial microbiota in paediatric patients with inflammatory bowel disease. Gut 2006;55:1760–1767.
  71. Schippa S, Conte MP, et al: dominant genotypes in mucosa-associated Escherichia coli strains from pediatric patients with inflammatory bowel disease. Inflamm Bowel Dis 2009;15:661–672.
  72. Vasquez N, Mangin I, et al: Patchy distribution of mucosal lesions in ileal Crohn’s disease is not linked to differences in the dominant mucosa-associated bacteria: a study using fluorescence in situ hybridization and temporal temperature gradient gel electrophoresis. Inflamm Bowel Dis 2007;13:684–692.
  73. Schippa S, Iebba V, Barbato M, Di Nardo G, Totino V, Checchi MP, Longhi C, Maiella G, Cucchiara S, Conte MP: A distinctive ‘microbial signature’ in celiac pediatric patients. BMC Microbiol 2010;10:175–185.
  74. Collado MC, Donat E, Ribes-Koninckx C, Calabuig M, Sanz Y: Imbalances in faecal and duodenal Bifidobacterium species composition in active and non-active coeliac disease. BMC Microbiol 2008;8:232.
  75. Collado MC, Donat E, Ribes-Koninckx C, Calabuig M, Sanz Y: Specific duodenal and faecal bacterial groups associated with paediatric coeliac disease. J Clin Pathol 2009;62:264–269.
  76. Finegold SM, Dowd SE, Gontcharova V, Liu C, Henley KE, Wolcott RD, Youn E, Summanen PH, Granpeesheh D, Dixon D, Liu M, Molitoris DR, Green JA 3rd: Pyrosequencing study of fecal microflora of autistic and control children. Anaerobe 2010;16:444–453.
  77. Yap IK, Angley M, Veselkov KA, Holmes E, Lindon JC, Nicholson JK: Urinary metabolic phenotyping differentiates children with autism from their unaffected siblings and age-matched controls. J Proteome Res 2010;9:2996–3004.

  

Author Contacts

Valerio Iebba
Microbiology Unit, Department of Public Health Sciences
Sapienza University of Rome, Piazzale Aldo Moro 5
IT–00185 Rome (Italy)
E-Mail valerio.iebba@uniroma1.it

  

Article Information

Number of Print Pages : 9

  

Publication Details

Digestive Diseases (Clinical Reviews)

Vol. 29, No. 6, Year 2011 (Cover Date: December 2011)

Journal Editor: Malfertheiner P. (Magdeburg)
ISSN: 0257-2753 (Print), eISSN: 1421-9875 (Online)

For additional information: http://www.karger.com/DDI


Copyright / Drug Dosage / Disclaimer

Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher or, in the case of photocopying, direct payment of a specified fee to the Copyright Clearance Center.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in goverment regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.

First-Page Preview
Abstract of Retracted Paper

  

Author Contacts

Valerio Iebba
Microbiology Unit, Department of Public Health Sciences
Sapienza University of Rome, Piazzale Aldo Moro 5
IT–00185 Rome (Italy)
E-Mail valerio.iebba@uniroma1.it

  

Article Information

Number of Print Pages : 9

  

Publication Details

Digestive Diseases (Clinical Reviews)

Vol. 29, No. 6, Year 2011 (Cover Date: December 2011)

Journal Editor: Malfertheiner P. (Magdeburg)
ISSN: 0257-2753 (Print), eISSN: 1421-9875 (Online)

For additional information: http://www.karger.com/DDI


Article / Publication Details

Published online: 12/12/2011
Issue release date: December 2011

Number of Print Pages: 9
Number of Figures: 1
Number of Tables: 0

ISSN: 0257-2753 (Print)
eISSN: 1421-9875 (Online)

For additional information: http://www.karger.com/DDI


Copyright / Drug Dosage

Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher or, in the case of photocopying, direct payment of a specified fee to the Copyright Clearance Center.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in goverment regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.